So, Alpelisib is this PI3K inhibitor thing. It’s specifically for people with Hormone Receptor-Positive/HER2-Negative breast cancer and those with PIK3CA mutations. It messes with the PI3K signaling pathway, if you know what I mean.
You’ve got the options with Alpelisib—50 mg, 200 mg, or the 300 mg film-coated tablets. The deal is, you go with the 300 mg, take it every day, and ideally, you take it with food. It comes in blister packs, 28 tabs a pop.
And if you follow the dose, that’s 28 days of treatment right there.
